SIX Swiss Exchange · Healthcare
Invest in Straumann stock from India
Indian and foreign residents can buy Straumann (STMN) shares directly through Paasa.
By Paasa · Updated
Straumann at a glance
- Price
- CHF 97.48+CHF 1.10 (1.14%)
- Market cap
- CHF 15.54B
- Day range
- CHF 96.36 – CHF 98.60
- P/E
- 41.84
- Dividend yield
- 1.03%
- Volume
- 273.89K
- 1 month
- +5.75%
- 6 months
- +19.75%
- YTD
- +3.37%
- 1 year
- +11.76%
- 5 years
- -45.02%
Straumann statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 2.6B | CHF 2.5B | CHF 2.4B | CHF 2.3B | CHF 2.0B |
| Gross profit | CHF 1.8B | CHF 1.8B | CHF 1.8B | CHF 1.7B | CHF 1.5B |
| Operating income | CHF 537.9M | CHF 601.0M | CHF 411.0M | CHF 530.5M | CHF 536.5M |
| Net income | CHF 355.9M | CHF 388.3M | CHF 246.1M | CHF 434.8M | CHF 396.1M |
| Earnings per share | CHF 2.24 | CHF 2.44 | CHF 1.54 | CHF 2.73 | CHF 2.49 |
| EBITDA | CHF 696.1M | CHF 726.2M | CHF 495.4M | CHF 678.3M | CHF 591.5M |
| Total assets | CHF 3.8B | CHF 3.6B | CHF 3.4B | CHF 3.5B | CHF 3.1B |
| Total debt | CHF 650.7M | CHF 460.9M | CHF 412.4M | CHF 705.2M | CHF 706.6M |
| Cash and short-term investments | CHF 489.6M | CHF 383.1M | CHF 413.5M | CHF 697.1M | CHF 881.5M |
| Shareholders' equity | CHF 2.2B | CHF 2.0B | CHF 1.8B | CHF 1.9B | CHF 1.5B |
| Operating cash flow | CHF 505.4M | CHF 483.4M | CHF 503.9M | CHF 416.4M | CHF 561.9M |
| Free cash flow | CHF 329.8M | CHF 315.6M | CHF 316.6M | CHF 220.9M | CHF 441.0M |
| Capital expenditure | −CHF 175.6M | −CHF 167.8M | −CHF 189.4M | −CHF 195.4M | −CHF 121.0M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Alcon | ALC.SW | CHF 53.30 | CHF 25.98B |
| Zimmer Biomet | ZBH.SW | CHF 77.50 | CHF 14.99B |
| Sonova | SOON.SW | CHF 241.00 | CHF 14.32B |
| Ypsomed | YPSN.SW | CHF 360.40 | CHF 4.74B |
| Galenica | GALE.SW | CHF 82.55 | CHF 4.11B |
| Tecan | TECN.SW | CHF 223.20 | CHF 2.82B |
| Medacta | MOVE.SW | CHF 114.00 | CHF 2.27B |
| SKAN | SKAN.SW | CHF 66.90 | CHF 1.50B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 1 buy · 0 hold · 0 sell. Consensus: Buy.
Published sell-side 12-month targets in CHF, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Straumann from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search STMN and buy
Find Straumann by name or by its ticker, STMN, and place your order.
Why invest in Straumann from India
What Straumann does
Straumann Holding AG is a global leader in providing advanced solutions for tooth replacement and orthodontic treatment. The company actively researches, develops, manufactures, and distributes a comprehensive range of dental products and services designed for tooth correction, restoration, replacement, and the prevention of tooth loss. Straumann operates in the Medical - Instruments & Supplies industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Straumann stock from India?
Yes. Indian residents and NRIs can buy Straumann (STMN) shares directly through Paasa. Straumann is listed on the SIX Swiss Exchange, in the Medical - Instruments & Supplies industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Straumann shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.